The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy
{{output}}
Hepatocellular carcinoma (HCC) is associated with a highly heterogeneous immune environment that produces an immune response to various locoregional treatments (LRTs), which in turn affects the effectiveness of immunotherapy. Although LRTs still dominate HCC t... ...
